Terms: = Leukemia AND ER, estrogen receptor AND Prognosis
47 results:
1. FLT3-ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia.
Turos-Cabal M; Sánchez-Sánchez AM; Puente-Moncada N; Herrera F; Antolin I; Rodríguez C; Martín V
Hematol Oncol; 2024 May; 42(3):e3281. PubMed ID: 38775115
[TBL] [Abstract] [Full Text] [Related]
2. C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Du M; Wang M; Liu M; Fu S; Lin Y; Huo Y; Yu J; Yu X; Wang C; Xiao H; Wang L
J Exp Clin Cancer Res; 2024 Mar; 43(1):79. PubMed ID: 38475919
[TBL] [Abstract] [Full Text] [Related]
3. Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F; Śniegocka M; Tito C; Iaiza A; Ottone T; Divona M; Travaglini S; Mattei M; Cicconi R; Miglietta S; Familiari G; Nottola SA; Petrozza V; Tamagnone L; Voso MT; Masciarelli S; Fazi F
J Exp Clin Cancer Res; 2023 Aug; 42(1):223. PubMed ID: 37653435
[TBL] [Abstract] [Full Text] [Related]
4. Endoplasmic reticulum stress-related signature predicts prognosis and immune infiltration analysis in acute myeloid leukemia.
Dong L; Wang H; Miao Z; Yu Y; Gai D; Zhang G; Ge L; Shen X
Hematology; 2023 Dec; 28(1):2246268. PubMed ID: 37589214
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatics analysis of the endoplasmic reticulum stress-related prognostic model and immune cell infiltration in acute myeloid leukemia.
Pan M; Zhou J; Jiao C; Ge J
Hematology; 2023 Dec; 28(1):2221101. PubMed ID: 37294065
[TBL] [Abstract] [Full Text] [Related]
6. Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy.
Song Z; Li C; Zhou D; Liu J; Qian X; Zhang J
Clin Breast Cancer; 2022 Jul; 22(5):e655-e663. PubMed ID: 35248490
[TBL] [Abstract] [Full Text] [Related]
7. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
Abdel Ghafar MT; Soliman NA
Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
[TBL] [Abstract] [Full Text] [Related]
8. Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance.
Fleischmann M; Fischer M; Schnetzke U; Fortner C; Kirkpatrick J; Heidel FH; Hochhaus A; Scholl S
Cells; 2021 Nov; 10(11):. PubMed ID: 34831215
[TBL] [Abstract] [Full Text] [Related]
9. rs6426881 in the 3'-UTR of PBX1 is involved in breast and gastric cancers via altering the binding potential of miR-522-3p.
Mohammadi M; Salehzadeh A; Talesh Sasani S; Tarang A
Mol Biol Rep; 2021 Nov; 48(11):7405-7414. PubMed ID: 34655407
[TBL] [Abstract] [Full Text] [Related]
10. The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation.
Sun L; Wang W; Han C; Huang W; Sun Y; Fang K; Zeng Z; Yang Q; Pan Q; Chen T; Luo X; Chen Y
Mol Cell; 2021 Nov; 81(21):4493-4508.e9. PubMed ID: 34555354
[TBL] [Abstract] [Full Text] [Related]
11. RUNX1T1, a potential prognostic marker in breast cancer, is co-ordinately expressed with ERα, and regulated by estrogen receptor signalling in breast cancer cells.
Saikia S; Pal U; Kalita DJ; Rai AK; Sarma A; Kataki AC; Limaye AM
Mol Biol Rep; 2021 Jul; 48(7):5399-5409. PubMed ID: 34264479
[TBL] [Abstract] [Full Text] [Related]
12. Bispecific Antibodies for Triple Negative Breast Cancer.
Dees S; Ganesan R; Singh S; Grewal IS
Trends Cancer; 2021 Feb; 7(2):162-173. PubMed ID: 33041246
[TBL] [Abstract] [Full Text] [Related]
13. Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.
Ikebe E; Matsuoka S; Tezuka K; Kuramitsu M; Okuma K; Nakashima M; Kobayashi S; Makiyama J; Yamagishi M; Oyadomari S; Uchimaru K; Hamaguchi I
Blood Adv; 2020 May; 4(9):1845-1858. PubMed ID: 32369565
[TBL] [Abstract] [Full Text] [Related]
14. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in estrogen receptor-Negative Breast Cancer via Data Mining.
Qiu Y; Lu G; Wu Y
J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
[TBL] [Abstract] [Full Text] [Related]
15. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
[TBL] [Abstract] [Full Text] [Related]
17. A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells.
Li Y; Zhang H; Zhao Y; Wang C; Cheng Z; Tang L; Gao Y; Liu F; Li J; Li Y; Li Y; Geng N; Rui X; Teng Y; Liu Y; Cao L; Kumar R; Jin F; Li F
Oncogene; 2019 Feb; 38(6):808-821. PubMed ID: 30177834
[TBL] [Abstract] [Full Text] [Related]
18. Acute Myeloid leukemia Following Gynecologic Cancer in the Era of Platinum-Based Chemotherapy.
Nasioudis D; Lontos K; Tsagianni A; Boyiadzis M; Ko EM
Int J Gynecol Cancer; 2018 Oct; 28(8):1639-1642. PubMed ID: 30095705
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Liang L; Wei DM; Li JJ; Luo DZ; Chen G; Dang YW; Cai XY
Mol Med Rep; 2018 Jan; 17(1):939-951. PubMed ID: 29115476
[TBL] [Abstract] [Full Text] [Related]
20. Expression Levels of KMT2C and SLC20A1 Identified by Information-theoretical Analysis Are Powerful Prognostic Biomarkers in estrogen receptor-positive Breast Cancer.
Sato K; Akimoto K
Clin Breast Cancer; 2017 Jun; 17(3):e135-e142. PubMed ID: 27986439
[TBL] [Abstract] [Full Text] [Related]
[Next]